288 related articles for article (PubMed ID: 26565388)
1. Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model.
He Q; Li YH; Guo SS; Wang Y; Lin W; Zhang Q; Wang J; Ma CG; Xiao BG
Eur J Neurosci; 2016 Jan; 43(1):41-52. PubMed ID: 26565388
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
[TBL] [Abstract][Full Text] [Related]
3. Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway.
Yan X; Liu DF; Zhang XY; Liu D; Xu SY; Chen GX; Huang BX; Ren WZ; Wang W; Fu SP; Liu JX
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28208679
[TBL] [Abstract][Full Text] [Related]
4. Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease.
Zhao YF; Zhang Q; Xi JY; Li YH; Ma CG; Xiao BG
J Neurol Sci; 2015; 353(1-2):28-37. PubMed ID: 25908255
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease.
Tönges L; Frank T; Tatenhorst L; Saal KA; Koch JC; Szego ÉM; Bähr M; Weishaupt JH; Lingor P
Brain; 2012 Nov; 135(Pt 11):3355-70. PubMed ID: 23087045
[TBL] [Abstract][Full Text] [Related]
6. Fasudil Enhances Therapeutic Efficacy of Neural Stem Cells in the Mouse Model of MPTP-Induced Parkinson's Disease.
Li YH; Yu JW; Xi JY; Yu WB; Liu JC; Wang Q; Song LJ; Feng L; Yan YP; Zhang GX; Xiao BG; Ma CG
Mol Neurobiol; 2017 Sep; 54(7):5400-5413. PubMed ID: 27590141
[TBL] [Abstract][Full Text] [Related]
7. Fasudil protects hippocampal neurons against hypoxia-reoxygenation injury by suppressing microglial inflammatory responses in mice.
Ding J; Li QY; Wang X; Sun CH; Lu CZ; Xiao BG
J Neurochem; 2010 Sep; 114(6):1619-29. PubMed ID: 20882700
[TBL] [Abstract][Full Text] [Related]
8. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection.
Sharma N; Sharma S; Nehru B
Inflammopharmacology; 2017 Jun; 25(3):351-368. PubMed ID: 28409389
[TBL] [Abstract][Full Text] [Related]
9. Further Characterization of Intrastriatal Lipopolysaccharide Model of Parkinson's Disease in C57BL/6 Mice.
Deng I; Corrigan F; Garg S; Zhou XF; Bobrovskaya L
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299000
[TBL] [Abstract][Full Text] [Related]
10. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
Niu H; Wang Q; Zhao W; Liu J; Wang D; Muhammad B; Liu X; Quan N; Zhang H; Zhang F; Wang Y; Li H; Yang R
Brain Pathol; 2020 Nov; 30(6):1102-1118. PubMed ID: 32678959
[TBL] [Abstract][Full Text] [Related]
11. Tenuigenin protects dopaminergic neurons from inflammation via suppressing NLRP3 inflammasome activation in microglia.
Fan Z; Liang Z; Yang H; Pan Y; Zheng Y; Wang X
J Neuroinflammation; 2017 Dec; 14(1):256. PubMed ID: 29262843
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
13. Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson's disease model.
Li YH; He Q; Yu JZ; Liu CY; Feng L; Chai Z; Wang Q; Zhang HZ; Zhang GX; Xiao BG; Ma CG
Metab Brain Dis; 2015 Oct; 30(5):1217-26. PubMed ID: 26084861
[TBL] [Abstract][Full Text] [Related]
14. Rg1 improves LPS-induced Parkinsonian symptoms in mice via inhibition of NF-κB signaling and modulation of M1/M2 polarization.
Liu JQ; Zhao M; Zhang Z; Cui LY; Zhou X; Zhang W; Chu SF; Zhang DY; Chen NH
Acta Pharmacol Sin; 2020 Apr; 41(4):523-534. PubMed ID: 32203085
[TBL] [Abstract][Full Text] [Related]
15. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
16. Rho kinase inhibition modulates microglia activation and improves survival in a model of amyotrophic lateral sclerosis.
Tönges L; Günther R; Suhr M; Jansen J; Balck A; Saal KA; Barski E; Nientied T; Götz AA; Koch JC; Mueller BK; Weishaupt JH; Sereda MW; Hanisch UK; Bähr M; Lingor P
Glia; 2014 Feb; 62(2):217-32. PubMed ID: 24311453
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease.
Elgueta D; Aymerich MS; Contreras F; Montoya A; Celorrio M; Rojo-Bustamante E; Riquelme E; González H; Vásquez M; Franco R; Pacheco R
Neuropharmacology; 2017 Feb; 113(Pt A):110-123. PubMed ID: 27693549
[TBL] [Abstract][Full Text] [Related]
18. Fasudil, a Rho kinase inhibitor, promotes the autophagic degradation of A53T α-synuclein by activating the JNK 1/Bcl-2/beclin 1 pathway.
Liu FT; Yang YJ; Wu JJ; Li S; Tang YL; Zhao J; Liu ZY; Xiao BG; Zuo J; Liu W; Wang J
Brain Res; 2016 Feb; 1632():9-18. PubMed ID: 26683082
[TBL] [Abstract][Full Text] [Related]
19. Fasudil attenuates aggregation of α-synuclein in models of Parkinson's disease.
Tatenhorst L; Eckermann K; Dambeck V; Fonseca-Ornelas L; Walle H; Lopes da Fonseca T; Koch JC; Becker S; Tönges L; Bähr M; Outeiro TF; Zweckstetter M; Lingor P
Acta Neuropathol Commun; 2016 Apr; 4():39. PubMed ID: 27101974
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-κB pathway.
Chen J; Sun Z; Jin M; Tu Y; Wang S; Yang X; Chen Q; Zhang X; Han Y; Pi R
J Neuroimmunol; 2017 Apr; 305():108-114. PubMed ID: 28284330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
